Levovanox

Vancomycin, the active ingredient in Levovanox, is a glycopeptide antibiotic presented as an oral formulation for gastrointestinal use. It targets severe Clostridioides difficile infection and other susceptible enteric bacterial infections in adult patients.

GNH USA supplies Levovanox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Levovanox (vancomycin) is used to treat infections of the gastrointestinal tract caused by susceptible bacteria. - Clostridioides difficile infection: eradicates toxin‑producing C. difficile in the colon, reducing diarrhea, colitis, and recurrence risk. - Enteric bacterial infections: treats susceptible Gram‑positive organisms such as Enterococcus spp. and Staphylococcus aureus causing gastrointestinal infection. - Severe bacterial enteritis: helps control infection by vancomycin‑sensitive bacteria in the intestines, improving clinical symptoms and preventing complications.

Oral vancomycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often reported. - Diarrhea: loose stools may occur. - Abdominal pain: cramping or discomfort in the gut. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Nephrotoxicity: potential kidney function impairment. - Ototoxicity: possible hearing loss or ringing in ears. - Severe allergic reaction: anaphylaxis or skin rash.

Before prescribing Levovanox, clinicians should consider several safety precautions to minimize risks. - Assess renal function: adjust therapy if creatinine clearance is reduced. - Monitor hearing: watch for signs of ototoxicity during treatment. - Evaluate for hypersensitivity: discontinue if rash, pruritus, or anaphylaxis occurs. - Use only for confirmed infection: limit to patients with documented C. difficile or susceptible enteric infection. - Avoid concomitant nephrotoxins: limit use with aminoglycosides or loop diuretics. - Store below 25°C: keep in the original packaging, protect from moisture and heat.

Vancomycin can interact with other medicines, affecting its safety or effectiveness.

Major Interactions (Avoid): - Aminoglycosides: combined use increases risk of nephrotoxicity. - Loop diuretics: may potentiate renal impairment. - NSAIDs: concurrent use can exacerbate kidney damage.

Moderate Interactions (Monitor Closely): - Oral antacids containing magnesium or aluminum: may reduce vancomycin absorption. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Phenytoin: may alter vancomycin plasma levels.